Amarin Corp Plcuk (AMRN) Cash & Current Investments (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Cash & Current Investments of $177.0 million for Q1 2026, up 8.88% YoY from $162.6 million in Q1 2025, and down 41.5% sequentially from $302.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Cash & Current Investments (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Cash & Current Investments across 17 years of filings, most recently posting $177.0 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 8.88% year-over-year to $177.0 million; the TTM figure through Mar 2026 stood at $177.0 million (up 8.88% YoY), while the FY2025 annual figure was $302.6 million, up 74.42% from the prior year.
  • Cash & Current Investments retreated to $177.0 million in Q1 2026, from $302.6 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for AMRN reached as high as $362.6 million in Q1 2022 and fell as low as $50.4 million in Q3 2023.
  • The 5-year median for Cash & Current Investments is $173.5 million (2024), against an average of $198.7 million.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 85.99% — and 2024, when it jumped 506.86%.
  • A 5-year view of Cash & Current Investments shows it stood at $92.2 million in 2022, then soared by 32.22% to $121.9 million in 2023, then soared by 42.28% to $173.5 million in 2024, then soared by 74.42% to $302.6 million in 2025, then slumped by 41.5% to $177.0 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $177.0 million, $302.6 million, and $164.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 22.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 9.39 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 7.94 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 5.70 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 7.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 13.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 100.00 Mn
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 177.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 177.00 Mn
Dec 31, 2025 302.59 Mn
Sep 30, 2025 164.10 Mn
Jun 30, 2025 298.70 Mn
Mar 31, 2025 162.56 Mn
Dec 31, 2024 173.48 Mn
Sep 30, 2024 305.69 Mn
Jun 30, 2024 306.60 Mn
Mar 31, 2024 94.76 Mn
Dec 31, 2023 121.93 Mn
Sep 30, 2023 50.37 Mn
Jun 30, 2023 80.42 Mn
Mar 31, 2023 304.37 Mn
Dec 31, 2022 92.22 Mn
Sep 30, 2022 67.12 Mn
Jun 30, 2022 313.23 Mn
Mar 31, 2022 362.61 Mn
Dec 31, 2021 454.13 Mn
Sep 30, 2021 479.20 Mn
Jun 30, 2021 185.83 Mn